Sort
30,917 grants matching “tumor microenvironment”
Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression
$370,575Guocan Wang · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Understanding and harnessing immune-modulatory effects of covalent KRASG12C inhibitors in KRASG12C-mutant non-small cell lung cancer
$370,575Ferdinandos Skoulidis · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Novel Mechanisms of Cancer Bone Metastasis
$370,575Yihong Wan · Ut Southwestern Medical Center · R01 · FY2020 · CA
Role of SAP30 in hypoxia inducible factor activation and breast cancer progression
$370,575Weibo Luo · Ut Southwestern Medical Center · R01 · FY2022 · CA
Nanoprobe-enabled Delineation of Tumor Margins for Improved Surgical Therapy
$370,575Jinming Gao · Ut Southwestern Medical Center · R01 · FY2017 · CA
Multiscale Image-based Modeling of Antiangiogenic Resistance in Breast Cancer
$370,575Arvind P Pathak · Johns Hopkins University · R01 · FY2017 · CA
Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages
$370,554James Louis Rubenstein · University Of California, San Francisco · R01 · FY2015 · CA
Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages
$370,554James Louis Rubenstein · University Of California, San Francisco · R01 · FY2018 · CA
Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages
$370,554James Louis Rubenstein · University Of California, San Francisco · R01 · FY2017 · CA
Recognition and Targeting of CNS Lymphoma by Tumor-Associated Macrophages
$370,554James Louis Rubenstein · University Of California, San Francisco · R01 · FY2016 · CA
Use of focused ultrasound to increase melanoma immunogenicity and inhibit tumor-induced T cell tolerance
$370,552Fernando Macian · Albert Einstein College Of Medicine · R01 · FY2019 · CA
Mechanistic investigations of microbiome-driven aryl hydrocarbon receptor activity and macrophage function in pancreatic cancer.
$370,513Tracy L McGaha · University Health Network · R01 · FY2025 · CA
Innate Immune Therapy for B-Cell Malignancies
$370,509John C Byrd · Ohio State University · P01 · FY2014 · CA
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2018 · CA
Develop a Therapeutic Nano-vaccine against Head and Neck Cancer
$370,500Yu Leo Lei · University Of Michigan At Ann Arbor · R01 · FY2019 · DE
Analyzing protein homeostasis pathways in multiple myeloma stem-like cells
$370,500Nami McCarty · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · CA
Develop a Therapeutic Nano-vaccine against Head and Neck Cancer
$370,500Yu Leo Lei · University Of Michigan At Ann Arbor · R01 · FY2020 · DE
Develop a Therapeutic Nano-vaccine against Head and Neck Cancer
$370,500Yu Leo Lei · University Of Michigan At Ann Arbor · R01 · FY2021 · DE
Analyzing protein homeostasis pathways in multiple myeloma stem-like cells
$370,500Nami McCarty · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · CA
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2021 · CA
Function of Membrane Type Matrix Metalloproteinase
$370,500Stephen Weiss · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Targeted therapies in cutaneous melanoma
$370,500Andrew E Aplin · Thomas Jefferson University · R01 · FY2020 · CA
Function of Membrane Type Matrix Metalloproteinase
$370,500Stephen Weiss · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Combinatorial Targeting of Epigenomic and Microenvironmental Pathways to Suppress MAPK Inhibitor Resistance in Melanoma
$370,500Roger S Lo · University Of California Los Angeles · R01 · FY2020 · CA
Function of Membrane Type Matrix Metalloproteinase
$370,500Stephen Weiss · University Of Michigan At Ann Arbor · R01 · FY2023 · CA